Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical predictors, microbiological profile, and outcomes of bacteremia in patients with cellulitis: a 6-year retrospective cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Computed Tomography Patterns of <i>Pneumocystis jirovecii</i> Pneumonia According to Immune Status.

Diagnostics (Basel, Switzerland)·2026
Same author

Pneumocystis jirovecii pneumonia in patients with and without HIV infection: A multicentre comparative study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Prognostic accuracy of severity grading score and severity scoring index for predicting severe outcomes in Crimean-Congo hemorrhagic fever: a systematic review and meta-analysis.

Infection·2026
Same author

Can Artificial Intelligence Optimize the Early Diagnosis of Invasive Candidiasis? A Systematic Review and Meta-Analysis.

Journal of fungi (Basel, Switzerland)·2026
Same author

Three Decades of Use of the Minimum Basic Data Set in Infectious Disease Research in Spain: A Scoping Review with an Evidence-Mapping Approach.

Tropical medicine and infectious disease·2026

Related Experiment Videos

[Ormond's disease: Experience with five cases].

Natalia Castro-Iglesias1, Moncef Belhassen-García, Virginia Velasco-Tirado

  • 1Servicio de Medicina Interna III, Hospital Clínico Universitario de Salamanca, Salamanca, España.

Reumatologia Clinica
|July 29, 2011
PubMed
Summary

Ormond's disease (OD) is a rare condition characterized by fibrotic masses. Current treatments lack clear guidelines, necessitating further research for improved patient outcomes.

Related Experiment Videos

Area of Science:

  • Urology
  • Vascular Surgery
  • Rheumatology

Context:

  • Ormond's disease (OD) is a rare condition with an incidence of approximately 1 per million.
  • Etiology is often unknown, with various pathogenic mechanisms implicated in secondary OD.
  • Characterized by fibrotic and inflammatory masses, presenting as retroperitoneal fibrosis, perianeurysmatic retroperitoneal fibrosis, or inflammatory abdominal aortic aneurysms.

Purpose:

  • To report five cases of Ormond's disease from the University Hospital of Salamanca (2000-2008).
  • To highlight the lack of clinical trials for established treatment guidelines.
  • To emphasize the need for improved patient outcomes.

Summary:

  • Five cases of Ormond's disease were observed between 2000 and 2008.
  • The disease presents with diverse clinical features including retroperitoneal fibrosis and inflammatory aneurysms.
  • Management typically involves surgery, steroids, or immunosuppressive agents with variable results.

Impact:

  • Underscores the need for evidence-based clinical guidelines for Ormond's disease management.
  • Highlights the importance of further research to improve treatment efficacy and patient outcomes.
  • Contributes to the understanding of this uncommon fibrotic condition.